Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
-
Clinical Benefit
Substantial
The actual benefit of the proprietary medicinal products is substantial.
Clinical Added Value
minor
BUCCOLAM offers a level IV improvement in actual benefit in the management of prolonged acute convulsive seizures in children and adolescents suffering from epilepsy in view of its buccal administration and presentation in ready-to-use syringe form.